Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial
PaperCitations, authors & open-access status
Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 4,795 citations, 2016 year and green oa status.
4,795
Citations
2016
Year
green
OA Status